Endothelial Progenitor Cells: Current Issues on Characterization and Challenging Clinical Applications

Stem Cell Reviews and Reports

Volumn 8, Issue 3, 2012, Pages 926-939

  Resch, Thomas ^a   Pircher, Andreas ^a   Kähler, Christian M ^a   Pratschke, Johann ^a   Hilbe, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Angiogenesis; Cell therapy; Cell transplantation; Characterizing EPC; Endothelial progenitor cells; Tumour vascularisation; Vasculogenesis

Indexed keywords

BIOLOGICAL MARKER;

ANGIOGENESIS; ANIMAL; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL MOTION; CYTOLOGY; ENDOTHELIUM; HUMAN; LUNG DISEASE; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; VASCULARIZATION;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM; HUMANS; LUNG DISEASES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84865564286     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9332-9     Document Type: Review

References (145)

1. Rumpold, H., Wolf, D., Koeck, R., & Gunsilius, E. (2004). Endothelial progenitor cells: A source for therapeutic vasculogenesis? Journal of Cellular and Molecular Medicine, 8(4), 509-518.
2. Young, P. P., Vaughan, D. E., & Hatzopoulos, A. K. (2007). Biologic properties of endothelial progenitor cells and their potential for cell therapy. Progress in Cardiovascular Diseases, 49(6), 421-429.
3. Sata, M., Fukuda, D., Tanaka, K., Kaneda, Y., Yashiro, H., & Shirakawa, I. (2005). The role of circulating precursors in vascular repair and lesion formation. Journal of Cellular and Molecular Medicine, 9(3), 557-568.
4. Iwami, Y., Masuda, H., & Asahara, T. (2004). Endothelial progenitor cells: Past, state of the art, and future. Journal of Cellular and Molecular Medicine, 8(4), 488-497.
5. Kovacic, J. C., Moore, J., Herbert, A., Ma, D., Boehm, M., & Graham, R. M. (2008). Endothelial progenitor cells, angioblasts, and angiogenesis-old terms reconsidered from a current perspective. Trends in Cardiovascular Medicine, 18(2), 45-51.
6. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der, Z. R., Li, T., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964-967.
7. Gill, M., Dias, S., Hattori, K., Rivera, M. L., Hicklin, D., Witte, L., et al. (2001). Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circulation Research, 88(2), 167-174.
8. Khoo, C. P., Pozzilli, P., & Alison, M. R. (2008). Endothelial progenitor cells and their potential therapeutic applications. Regenerative Medicine, 3(6), 863-876.
9. Rafii, S., Lyden, D., Benezra, R., Hattori, K., & Heissig, B. (2002). Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nature Reviews. Cancer, 2(11), 826-835.
10. Dome, B., Dobos, J., Tovari, J., Paku, S., Kovacs, G., Ostoros, G., et al. (2008). Circulating bone marrow-derived endothelial progenitor cells: Characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry. Part A, 73(3), 186-193.
11. Miller-Kasprzak, E., & Jagodzinski, P. P. (2007). Endothelial progenitor cells as a new agent contributing to vascular repair. Archivum Immunologiae et Therapiae Experimentalis, 55(4), 247-259.
12. Rafii, D. C., Psaila, B., Butler, J., Jin, D. K., & Lyden, D. (2008). Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(2), 217-222.
13. Brixius, K., Funcke, F., Graf, C., & Bloch, W. (2006). Endothelial progenitor cells: A new target for the prevention of cardiovascular diseases. European Journal of Cardiovascular Prevention and Rehabilitation, 13(5), 705-710.
14. Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegue, E., et al. (2008). HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell, 13(3), 206-220.
15. Hristov, M., Erl, W., & Weber, P. C. (2003). Endothelial progenitor cells: Mobilization, differentiation, and homing. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(7), 1185-1189.
16. Werner, N., & Nickenig, G. (2006). Influence of cardiovascular risk factors on endothelial progenitor cells: Limitations for therapy? Arteriosclerosis, Thrombosis, and Vascular Biology, 26(2), 257-266.
17. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., et al. (2008). Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117(4), e25-e146.
18. Tongers, J., & Losordo, D. W. (2007). Frontiers in nephrology: The evolving therapeutic applications of endothelial progenitor cells. Journal of the American Society of Nephrology, 18(11), 2843-2852.
19. Roberts, N., Jahangiri, M., & Xu, Q. (2005). Progenitor cells in vascular disease. Journal of Cellular and Molecular Medicine, 9(3), 583-591.
20. Goon, P. K., Lip, G. Y., Boos, C. J., Stonelake, P. S., & Blann, A. D. (2006). Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia, 8(2), 79-88.
21. Naumov, G. N., Folkman, J., Straume, O., & Akslen, L. A. (2008). Tumor-vascular interactions and tumor dormancy. APMIS, 116(7-8), 569-585.
22. Ergun, S., Hohn, H. P., Kilic, N., Singer, B. B., & Tilki, D. (2008). Endothelial and hematopoietic progenitor cells (EPCs and HPCs): Hand in hand fate determining partners for cancer cells. Stem Cell Reviews, 4(3), 169-177.
23. Ribatti, D. (2004). The involvement of endothelial progenitor cells in tumor angiogenesis. Journal of Cellular and Molecular Medicine, 8(3), 294-300.
24. Urbich, C., & Dimmeler, S. (2004). Endothelial progenitor cells: Characterization and role in vascular biology. Circulation Research, 95(4), 343-353.
25. Peichev, M., Naiyer, A. J., Pereira, D., Zhu, Z., Lane, W. J., Williams, M., et al. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95(3), 952-958.
26. Case, J., Mead, L. E., Bessler, W. K., Prater, D., White, H. A., Saadatzadeh, M. R., et al. (2007). Human CD34 + AC133 + VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Experimental Hematology, 35(7), 1109-1118.
27. Aoki, M., Yasutake, M., & Murohara, T. (2004). Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells, 22(6), 994-1002.
28. Navarro-Sobrino, M., Rosell, A., Hernandez-Guillamon, M., Penalba, A., Ribo, M., Alvarez-Sabin, J., et al. (2010). Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvascular Research, 80(3), 317-323.
29. Rae, P. C., Kelly, R. D., Egginton, S., & St John, J. C. (2011). Angiogenic potential of endothelial progenitor cells and embryonic stem cells. Vascular Cell, 3, 11.
30. Bertolini, F., Shaked, Y., Mancuso, P., & Kerbel, R. S. (2006). The multifaceted circulating endothelial cell in cancer: Towards marker and target identification. Nature Reviews. Cancer, 6(11), 835-845.
31. Huang, E. H., & Wicha, M. S. (2008). Colon cancer stem cells: Implications for prevention and therapy. Trends in Molecular Medicine, 14(11), 503-509.
32. Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., et al. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90(12), 5002-5012.
33. Miraglia, S., Godfrey, W., Yin, A. H., Atkins, K., Warnke, R., Holden, J. T., et al. (1997). A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood, 90(12), 5013-5021.
34. Ribatti, D. (2007). The discovery of endothelial progenitor cells. An historical review. Leukemia Research, 31(4), 439-444.
35. Reinders, M. E., Rabelink, T. J., & Briscoe, D. M. (2006). Angiogenesis and endothelial cell repair in renal disease and allograft rejection. Journal of the American Society of Nephrology, 17(4), 932-942.
36. Faltas, B., Zeidan, A., Peters, K., Das, A., Joudeh, J., Navaraj, A., et al. (2011). Identifying circulating tumor stem cells that matter: The key to prognostication and therapeutic targeting. Journal of Clinical Oncology, 29(21), 2946-2947.
37. Florek, M., Haase, M., Marzesco, A. M., Freund, D., Ehninger, G., Huttner, W. B., et al. (2005). Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell and Tissue Research, 319(1), 15-26.
38. Iinuma, H., Watanabe, T., Mimori, K., Adachi, M., Hayashi, N., Tamura, J., et al. (2011). Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. Journal of Clinical Oncology, 29(12), 1547-1555.
39. Sullivan, J. P., Spinola, M., Dodge, M., Raso, M. G., Behrens, C., Gao, B., et al. (2010). Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Research, 70(23), 9937-9948.
40. Matsumoto, T., & Mugishima, H. (2006). Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. Journal of Atherosclerosis and Thrombosis, 13(3), 130-135.
41. Ahlbrecht, K., Schmitz, J., Seay, U., Schwarz, C., Mittnacht-Kraus, R., Gaumann, A., et al. (2008). Spatiotemporal expression of flk-1 in pulmonary epithelial cells during lung development. American Journal of Respiratory Cell and Molecular Biology, 39(2), 163-170.
42. Matsumoto, T., & Claesson-Welsh, L. (2001). VEGF receptor signal transduction. Science's STKE, 2001(112), RE21.
43. Shibuya, M. (2006). Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. Journal of Biochemistry and Molecular Biology, 39(5), 469-478.
44. Quirici, N., Soligo, D., Caneva, L., Servida, F., Bossolasco, P., & Deliliers, G. L. (2001). Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. British Journal of Haematology, 115(1), 186-194.
45. Kaushal, S., Amiel, G. E., Guleserian, K. J., Shapira, O. M., Perry, T., Sutherland, F. W., et al. (2001). Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nature Medicine, 7(9), 1035-1040.
46. Mohle, R., Bautz, F., Rafii, S., Moore, M. A., Brugger, W., & Kanz, L. (1998). The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood, 91(12), 4523-4530.
47. Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., et al. (1987). Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO Journal, 6(11), 3341-3351.
48. Sharma, S., Gurudutta, G. U., Satija, N. K., Pati, S., Afrin, F., Gupta, P., et al. (2006). Stem cell c-KIT and HOXB4 genes: Critical roles and mechanisms in self-renewal, proliferation, and differentiation. Stem Cells and Development, 15(6), 755-778.
49. Baggiolini, M. (2001). Chemokines in pathology and medicine. Journal of Internal Medicine, 250(2), 91-104.
50. Ashman, L. K. (1999). The biology of stem cell factor and its receptor C-kit. The International Journal of Biochemistry & Cell Biology, 31(10), 1037-1051.
51. Sharpe, E. E., III, Teleron, A. A., Li, B., Price, J., Sands, M. S., Alford, K., et al. (2006). The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells. American Journal of Pathology, 168(5), 1710-1721.
52. Hur, J., Yoon, C. H., Kim, H. S., Choi, J. H., Kang, H. J., Hwang, K. K., et al. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(2), 288-293.
53. Duan, H. X., Cheng, L. M., Wang, J., Hu, L. S., & Lu, G. X. (2006). Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood. Cell Biology International, 30(12), 1018-1027.
54. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10(8), 858-864.
55. Kleinman, M. E., Greives, M. R., Churgin, S. S., Blechman, K. M., Chang, E. I., Ceradini, D. J., et al. (2007). Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(12), 2664-2670.
56. Rabelink, T. J., de Boer, H. C., de Koning, E. J., & van Zonneveld, A. J. (2004). Endothelial progenitor cells: More than an inflammatory response? Arteriosclerosis, Thrombosis, and Vascular Biology, 24(5), 834-838.
57. Safran, M., & Kaelin, W. G., Jr. (2003). HIF hydroxylation and the mammalian oxygen-sensing pathway. The Journal of Clinical Investigation, 111(6), 779-783.
58. Hoenig, M. R., Bianchi, C., & Sellke, F. W. (2008). Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: A unifying hypothesis. Current Drug Targets, 9(5), 422-435.
59. Luttun, A., Carmeliet, G., & Carmeliet, P. (2002). Vascular progenitors: From biology to treatment. Trends in Cardiovascular Medicine, 12(2), 88-96.
60. Fox, A., Smythe, J., Fisher, N., Tyler, M. P., McGrouther, D. A., Watt, S. M., et al. (2008). Mobilization of endothelial progenitor cells into the circulation in burned patients. British Journal of Surgery, 95(2), 244-251.
61. Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., et al. (2003). Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood, 102(4), 1340-1346.
62. Bahlmann, F. H., De Groot, K., Spandau, J. M., Landry, A. L., Hertel, B., Duckert, T., et al. (2004). Erythropoietin regulates endothelial progenitor cells. Blood, 103(3), 921-926.
63. Ito, H., Rovira, I. I., Bloom, M. L., Takeda, K., Ferrans, V. J., Quyyumi, A. A., et al. (1999). Endothelial progenitor cells as putative targets for angiostatin. Cancer Research, 59(23), 5875-5877.
64. Urbich, C., Aicher, A., Heeschen, C., Dernbach, E., Hofmann, W. K., Zeiher, A. M., et al. (2005). Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. Journal of Molecular and Cellular Cardiology, 39(5), 733-742.
65. Westerweel, P. E., Visseren, F. L., Hajer, G. R., Olijhoek, J. K., Hoefer, I. E., de Bree, P., et al. (2008). Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. European Heart Journal, 29(22), 2808-2817.
66. Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jurgens, K., et al. (2004). Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation, 109(2), 220-226.
67. Fadini, G. P., de Kreutzenberg, S., Albiero, M., Coracina, A., Pagnin, E., Baesso, I., et al. (2008). Gender differences in endothelial progenitor cells and cardiovascular risk profile: The role of female estrogens. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(5), 997-1004.
68. Papayannopoulou, T. (2004). Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood, 103(5), 1580-1585.
69. Hill, J. M., Zalos, G., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. The New England Journal of Medicine, 348(7), 593-600.
70. Wilson, P. W., Castelli, W. P., & Kannel, W. B. (1987). Coronary risk prediction in adults (the Framingham Heart Study). The American Journal of Cardiology, 59(14), 91G-94G.
71. Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W. M., Silver, M., Kearney, M., et al. (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences of the United States of America, 97(7), 3422-3427.
72. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7(4), 430-436.
73. Shi, Q., Rafii, S., Wu, M. H., Wijelath, E. S., Yu, C., Ishida, A., et al. (1998). Evidence for circulating bone marrow-derived endothelial cells. Blood, 92(2), 362-367.
74. Ohtsuka, M., Takano, H., Zou, Y., Toko, H., Akazawa, H., Qin, Y., et al. (2004). Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. The FASEB Journal, 18(7), 851-853.
75. Ince, H., Petzsch, M., Kleine, H. D., Eckard, H., Rehders, T., Burska, D., et al. (2005). Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: Final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation, 112(9 Suppl), I73-I80.
76. Strauer, B. E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R. V., et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106(15), 1913-1918.
77. Assmus, B., Schachinger, V., Teupe, C., Britten, M., Lehmann, R., Dobert, N., et al. (2002). Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation, 106(24), 3009-3017.
78. Fernandez-Aviles, F., San Roman, J. A., Garcia-Frade, J., Fernandez, M. E., Penarrubia, M. J., de la, F. L., et al. (2004). Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circulation Research, 95(7), 742-748.
79. Schachinger, V., Assmus, B., Britten, M. B., Honold, J., Lehmann, R., Teupe, C., et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology, 44(8), 1690-1699.
80. Leistner, D. M., Fischer-Rasokat, U., Honold, J., Seeger, F. H., Schachinger, V., Lehmann, R. et al. (2011). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): Final 5-year results suggest long-term safety and efficacy. Clinical Research in Cardiology.
81. Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet, 364(9429), 141-148.
82. Wei, H. M., Wong, P., Hsu, L. F., & Shim, W. (2009). Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: Current status and future directions. Singapore Medical Journal, 50(10), 935-942.
83. Tse, H. F., Kwong, Y. L., Chan, J. K., Lo, G., Ho, C. L., & Lau, C. P. (2003). Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet, 361(9351), 47-49.
84. Hamano, K., Nishida, M., Hirata, K., Mikamo, A., Li, T. S., Harada, M., et al. (2001). Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: Clinical trial and preliminary results. Japanese Circulation Journal, 65(9), 845-847.
85. Perin, E. C., Dohmann, H. F., Borojevic, R., Silva, S. A., Sousa, A. L., Mesquita, C. T., et al. (2003). Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 107(18), 2294-2302.
86. Hattori, R., & Matsubara, H. (2004). Therapeutic angiogenesis for severe ischemic heart diseases by autologous bone marrow cells transplantation. Molecular and Cellular Biochemistry, 264(1-2), 151-155.
87. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., et al. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet, 360(9331), 427-435.
88. Matoba, S., Tatsumi, T., Murohara, T., Imaizumi, T., Katsuda, Y., Ito, M., et al. (2008). Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. American Heart Journal, 156(5), 1010-1018.
89. Fadini, G. P., Avogaro, A., Ferraccioli, G., & Agostini, C. (2010). Endothelial progenitors in pulmonary hypertension: New pathophysiology and therapeutic implications. European Respiratory Journal, 35(2), 418-425.
90. Fukumoto, Y., & Shimokawa, H. (2011). Recent progress in the management of pulmonary hypertension. Circulation Journal, 75(8), 1801-1810.
91. Diller, G. P., van Eijl, S., Okonko, D. O., Howard, L. S., Ali, O., Thum, T., et al. (2008). Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation, 117(23), 3020-3030.
92. Fadini, G. P., Schiavon, M., Rea, F., Avogaro, A., & Agostini, C. (2007). Depletion of endothelial progenitor cells may link pulmonary fibrosis and pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 176(7), 724-725.
93. Nathan, S. D., Noble, P. W., & Tuder, R. M. (2007). Idiopathic pulmonary fibrosis and pulmonary hypertension: Connecting the dots. American Journal of Respiratory and Critical Care Medicine, 175(9), 875-880.
94. Thebaud, B., & Abman, S. H. (2007). Bronchopulmonary dysplasia: Where have all the vessels gone? roles of angiogenic growth factors in chronic lung disease. American Journal of Respiratory and Critical Care Medicine, 175(10), 978-985.
95. Zhao, Y. D., Courtman, D. W., Deng, Y., Kugathasan, L., Zhang, Q., & Stewart, D. J. (2005). Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: Efficacy of combined cell and eNOS gene therapy in established disease. Circulation Research, 96(4), 442-450.
96. Yip, H. K., Chang, L. T., Sun, C. K., Sheu, J. J., Chiang, C. H., Youssef, A. A., et al. (2008). Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Critical Care Medicine, 36(3), 873-880.
97. Takahashi, M., Nakamura, T., Toba, T., Kajiwara, N., Kato, H., & Shimizu, Y. (2004). Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Engineering, 10(5-6), 771-779.
98. Wang, X. X., Zhang, F. R., Shang, Y. P., Zhu, J. H., Xie, X. D., Tao, Q. M., et al. (2007). Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: A pilot randomized controlled trial. Journal of the American College of Cardiology, 49(14), 1566-1571.
99. Shaked, Y., Henke, E., Roodhart, J. M., Mancuso, P., Langenberg, M. H., Colleoni, M., et al. (2008). Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: Implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell, 14(3), 263-273.
100. Toshner, M., Voswinckel, R., Southwood, M., Al Lamki, R., Howard, L. S., Marchesan, D., et al. (2009). Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 180(8), 780-787.
101. Marsboom, G., Pokreisz, P., Gheysens, O., Vermeersch, P., Gillijns, H., Pellens, M., et al. (2008). Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension. Stem Cells, 26(4), 1017-1026.
102. Sala, E., Villena, C., Balaguer, C., Rios, A., Fernandez-Palomeque, C., Cosio, B. G., et al. (2010). Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD. Lung, 188(4), 331-338.
103. Valipour, A., Schreder, M., Wolzt, M., Saliba, S., Kapiotis, S., Eickhoff, P., et al. (2008). Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clinical Science (London, England), 115(7), 225-232.
104. Takahashi, T., Suzuki, S., Kubo, H., Yamaya, M., Kurosawa, S., & Kato, M. (2011). Impaired endothelial progenitor cell mobilization and colony-forming capacity in chronic obstructive pulmonary disease. Respirology, 16(4), 680-687.
105. Yamada, M., Kubo, H., Ishizawa, K., Kobayashi, S., Shinkawa, M., & Sasaki, H. (2005). Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: Evidence that bone marrow derived cells contribute to lung repair. Thorax, 60(5), 410-413.
106. Burnham, E. L., Taylor, W. R., Quyyumi, A. A., Rojas, M., Brigham, K. L., & Moss, M. (2005). Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. American Journal of Respiratory and Critical Care Medicine, 172(7), 854-860.
107. Balasubramaniam, V., Mervis, C. F., Maxey, A. M., Markham, N. E., & Abman, S. H. (2007). Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: Implications for the pathogenesis of bronchopulmonary dysplasia. American Journal of Physiology. Lung Cellular and Molecular Physiology, 292(5), L1073-L1084.
108. Borghesi, A., Massa, M., Campanelli, R., Bollani, L., Tzialla, C., Figar, T. A., et al. (2009). Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine, 180(6), 540-546.
109. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., et al. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine, 7(11), 1194-1201.
110. Peters, B. A., Diaz, L. A., Polyak, K., Meszler, L., Romans, K., Guinan, E. C., et al. (2005). Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nature Medicine, 11(3), 261-262.
111. Mancuso, P., Burlini, A., Pruneri, G., Goldhirsch, A., Martinelli, G., & Bertolini, F. (2001). Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood, 97(11), 3658-3661.
112. Kerbel, R. S. (2008). Tumor angiogenesis. The New England Journal of Medicine, 358(19), 2039-2049.
113. Dome, B., Timar, J., Dobos, J., Meszaros, L., Raso, E., Paku, S., et al. (2006). Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Research, 66(14), 7341-7347.
114. Bergers, G., & Hanahan, D. (2008). Modes of resistance to anti-angiogenic therapy. Nature Reviews. Cancer, 8(8), 592-603.
115. Shaked, Y., Ciarrocchi, A., Franco, M., Lee, C. R., Man, S., Cheung, A. M., et al. (2006). Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science, 313(5794), 1785-1787.
116. Shirakawa, K., Shibuya, M., Heike, Y., Takashima, S., Watanabe, I., Konishi, F., et al. (2002). Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. International Journal of Cancer, 99(3), 344-351.
117. Sussman, L. K., Upalakalin, J. N., Roberts, M. J., Kocher, O., & Benjamin, L. E. (2003). Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biology & Therapy, 2(3), 255-256.
118. Yu, D., Sun, X., Qiu, Y., Zhou, J., Wu, Y., Zhuang, L., et al. (2007). Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clinical Cancer Research, 13(13), 3814-3824.
119. Gunsilius, E., Tschmelitsch, J., Eberwein, M., Schwelberger, H., Spizzo, G., Kahler, C. M., et al. (2002). In vivo release of vascular endothelial growth factor from colorectal carcinomas. Oncology, 62(4), 313-317.
120. Zheng, P. P., Hop, W. C., Luider, T. M., Sillevis Smitt, P. A., & Kros, J. M. (2007). Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas. Annals of Neurology, 62(1), 40-48.
121. Igreja, C., Courinha, M., Cachaco, A. S., Pereira, T., Cabecadas, J., da Silva, M. G., et al. (2007). Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica, 92(4), 469-477.
122. Zhang, H., Vakil, V., Braunstein, M., Smith, E. L., Maroney, J., Chen, L., et al. (2005). Circulating endothelial progenitor cells in multiple myeloma: Implications and significance. Blood, 105(8), 3286-3294.
123. Rigolin, G. M., Mauro, E., Ciccone, M., Fraulini, C., Sofritti, O., Castoldi, G., et al. (2007). Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. European Journal of Haematology, 78(5), 365-373.
124. Wierzbowska, A., Robak, T., Krawczynska, A., Wrzesien-Kus, A., Pluta, A., Cebula, B., et al. (2005). Circulating endothelial cells in patients with acute myeloid leukemia. European Journal of Haematology, 75(6), 492-497.
125. Auberger, J., Dlaska, M., Auberger, T., Gunsilius, E., Woll, E., & Hilbe, W. (2005). Increased CD133 expression in bone marrow of myelodysplastic syndromes. Leukemia Research, 29(9), 995-1001.
126. Gao, D., Nolan, D. J., Mellick, A. S., Bambino, K., McDonnell, K., & Mittal, V. (2008). Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science, 319(5860), 195-198.
127. Fontanini, G., Lucchi, M., Vignati, S., Mussi, A., Ciardiello, F., De Laurentiis, M., et al. (1997). Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study. Journal of the National Cancer Institute, 89(12), 881-886.
128. Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., et al. (2006). Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. The New England Journal of Medicine, 355(24), 2542-2550.
129. Reck, M., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V., Hirsh, V., et al. (2009). Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. Journal of Clinical Oncology, 27(8), 1227-1234.
130. Hilbe, W., Dirnhofer, S., Oberwasserlechner, F., Schmid, T., Gunsilius, E., Hilbe, G., et al. (2004). CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. Journal of Clinical Pathology, 57(9), 965-969.
131. Pircher, A., Kahler, C. M., Skvortsov, S., Dlaska, M., Kawaguchi, G., Schmid, T., et al. (2008). Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: A methodological challenge and an ongoing debate on the clinical relevance. Oncology Reports, 19(2), 345-352.
132. Bogos, K., Renyi-Vamos, F., Dobos, J., Kenessey, I., Tovari, J., Timar, J., et al. (2009). High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clinical Cancer Research, 15(5), 1741-1746.
133. Furstenberger, G., von Moos, R., Lucas, R., Thurlimann, B., Senn, H. J., Hamacher, J., et al. (2006). Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. British Journal of Cancer, 94(4), 524-531.
134. Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., et al. (2007). Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. The New England Journal of Medicine, 357(26), 2666-2676.
135. Goodale, D., Phay, C., Brown, W., Gray-Statchuk, L., Furlong, P., Lock, M., et al. (2009). Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer. Cytometry. Part B, Clinical Cytometry, 76(2), 107-117.
136. Goon, P. K., Lip, G. Y., Stonelake, P. S., & Blann, A. D. (2009). Circulating endothelial cells and circulating progenitor cells in breast cancer: Relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. Neoplasia, 11(8), 771-779.
137. Naik, R. P., Jin, D., Chuang, E., Gold, E. G., Tousimis, E. A., Moore, A. L., et al. (2008). Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Research and Treatment, 107(1), 133-138.
138. Ho, J. W., Pang, R. W., Lau, C., Sun, C. K., Yu, W. C., Fan, S. T., et al. (2006). Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology, 44(4), 836-843.
139. Jakob, C., Sterz, J., Zavrski, I., Heider, U., Kleeberg, L., Fleissner, C., et al. (2006). Angiogenesis in multiple myeloma. European Journal of Cancer, 42(11), 1581-1590.
140. Braunstein, M., Ozcelik, T., Bagislar, S., Vakil, V., Smith, E. L., Dai, K., et al. (2006). Endothelial progenitor cells display clonal restriction in multiple myeloma. BMC Cancer, 6, 161.
141. Purhonen, S., Palm, J., Rossi, D., Kaskenpaa, N., Rajantie, I., Yla-Herttuala, S., et al. (2008). Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 105(18), 6620-6625.
142. Kerbel, R. S., Benezra, R., Lyden, D. C., Hattori, K., Heissig, B., Nolan, D. J., et al. (2008). Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas. Proceedings of the National Academy of Sciences of the United States of America, 105(34), E54.
143. Yoder, M. C., Mead, L. E., Prater, D., Krier, T. R., Mroueh, K. N., Li, F., et al. (2007). Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109(5), 1801-1809.
144. Duda, D. G., Cohen, K. S., Scadden, D. T., & Jain, R. K. (2007). A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nature Protocols, 2(4), 805-810.
145. Steurer, M., Kern, J., Zitt, M., Amberger, A., Bauer, M., Gastl, G., et al. (2008). Quantification of circulating endothelial and progenitor cells: Comparison of quantitative PCR and four-channel flow cytometry. BMC Research Notes, 1, 71.